BlackBerry Gets Downgraded to Sell Along With Host of Other Stocks

Andrew Klips |

BlackBerry Gets Downgraded to Sell Along With Host of Other StocksEvery day is greeted with a series of changes in analysts opinions. Friday was no different with several big names getting cut to “sell” ratings, including:

BlackBerry (BBRY) was downgraded to a sell rating from neutral by MKM Partners. MKM citing concerns over the likelihood of success in the company’s new BlackBerry 10 phones and operating system. MKM believes that the odds of failure outweigh the chance of success with sales already stalling in the United Kingdom and a far smaller selection of popular applications.  Analysts lowered their price target from $12.00 to $10.00. Shares of BBRY are trading down 3 percent at $13.50 in early morning trading.



Agrium, Inc. (AGU) was downgraded by Dahlman Rose from a buy rating to a sell rating.  Dahlman Rose holds a price target of $88.00 for Agrium shares.  The reasons for the downgrade were more industry-wide as Dahlman believes the nitrogen, phosphorous and potassium markets are facing stiff headwinds for future growth.  Shares of AGU have fallen more than 6 percent in Friday morning trading to $100.

Dahlman wasn’t done with fertilizer play downgrades. Analysts also slashed CF Industries Holdings, Inc. (CF) from buy to sell on Friday with a price target of $170.00. That’s a 17 percent downside from Thursday’s closing price.  Shares have shed 1.6 percent to $200 this morning.

Newfield Exploration Co. (NFX) was downgraded by the computer-based metrics at TheStreet from a hold to a sell rating.  Reasons cited were weakness in multiple areas, including a high debt-to-equity ratio of 1:10, deteriorating net income in the latest quarter compared to the year prior quarter and “generally disappointing historical performance in the stock itself.” Despite the downgrade, shares are ahead by about 1 percent this morning after plummeting about 20 percent in the past five days.

C.R. Bard, Inc. (BCR) was downgraded by analysts at Goldman Sachs from neutral to a sell. Goldman’s 12-month price target for the stock was lowered from $99.00 to $95.00. The firm noted risks associated with clinical trials and an expanding P/E ratio while earnings estimates were lowered as rationale for the ratings cut. Shares of BCR are down by less than 1 percent at $98 in morning trading.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
BCR C.R. Bard Inc. 332.80 0.73 0.22 909,299 Trade
CF CF Industries Holdings Inc. 39.26 1.04 2.72 4,567,248 Trade
AGU Agrium Inc. 106.13 0.24 0.23 277,174 Trade
GDEN Golden Entertainment Inc. 33.20 0.45 1.37 82,439 Trade
NFX Newfield Exploration Company 29.39 0.53 1.84 2,781,178 Trade
BBRY BlackBerry Limited n/a n/a n/a n/a

Comments

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is engaged in the investment, acquisition and development of synergistic businesses in an effort to increase and sustain growth and value.

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…